“We use cookies on this website to enhance your user experience and to personalise content. By clicking any link or continuing to use our Website you agree to our cookies as per our Privacy Policy. Read More” Ok, I agree

Insulin Human (Myxredlin)

Trade Name : MYXREDLIN

Baxter Healthcare Corporation

INJECTION, SOLUTION

Strength 1 [iU]/mL

INSULIN HUMAN Insulin [EPC],Insulin [CS]

Delivery Process

Submit a Request

You can fill in a request for your medicine through the form provided. You can access the form by clicking on the ‘Get Price’ button.

We’ll Get in Touch

Once we review your request, we’ll send you an estimated price for the medicine within 2-5 days.

Confirmation and Payment

You can fill in a request for your medicine through the form provided. You can access the form by clicking on the ‘Get Price’ button.

Submit a Request

You can fill in a request for your medicine through the form provided. You can access the form by clicking on the ‘Get Price’ button.

Product information is meant for

Wholesalers Suppliers Exporters Doctors MOH Tender Supplies Hospitals Brand CROs Comparator Supplies Generic Cooperate Sourcing Individual Patients Indian Institutional Buyers

Disclaimer

Trade Marks displayed in compliance with provisions of: Trademark Act, 1999 u/s 30 and 30 (1) of "Fair use"

GNH India is WHO GDP and ISO 9001 2015 Certified Pharmaceutical Wholesaler/ Supplier/ Exporters/ Importer from India of Insulin Human (Myxredlin) which is also known as MYXREDLIN and Manufactured by Baxter Healthcare Corporation. It is available in strength of 1 [iU]/mL per ml. Read more

Insulin Human (Myxredlin) is supplied for Tenders/ Emergency imports/ Un - licensed, Specials, Orphan drug/ Name patient line/ RLD supplies/ Reference listed drugs/ Comparator Drug/ Bio-Similar/ Innovator samples For Clinical trials.  Click to know price.     Read less

Packaging and Delivery

Validated Cold Chain Shipment

We deliver your medicines through a validated cold chain shipment process. This process is used as these medicines need to manufactured, transported and stored at very specific temperatures, utilizing thermal and refrigerated packaging methods.

Inquire directly from our website and get 5% off on any medicine!

We deliver your medicines through a validated cold chain shipment process. This process is used as these medicines need to manufactured, transported and stored at very specific temperatures, utilizing thermal and refrigerated packaging methods.

Read more

About GNH

We deliver your medicines through a validated cold chain shipment process. This process is used as these medicines need to manufactured, transported and stored at very specific temperatures, utilizing thermal and refrigerated packaging methods.

We deliver your medicines through a validated cold chain shipment process. This process is used as these medicines need to manufactured, transported and stored at very specific temperatures, utilizing thermal and refrigerated packaging methods.

Read more
  • No data
  • MYXREDLIN is indicated to improve glycemic control in adults and pediatric patients with diabetes mellitus.
  • MYXREDLIN is a short-acting human insulin indicated to improve glycemic control in adults and pediatric patients with diabetes mellitus ().
  • No data
  • Array
  • Injection: 100 units insulin human in 100 mL of 0.9% sodium chloride (1 unit per mL) as a clear, colorless solution in a single-dose container.
  • Injection: 100 units insulin human in 100 mL of 0.9% sodium chloride (1 unit/mL) in a single-dose container ()
  • MYXREDLIN is contraindicated:
  • No data
  • Hyper- or Hypoglycemia with Changes in Insulin Regimen:
  • Hypoglycemia:
  • Hypersensitivity Reactions:
  • Hypokalemia:
  • Fluid Retention and Heart Failure with Concomitant Use of Thiazolidinediones (TZDs):
  • The following adverse reactions are also discussed elsewhere in the labeling:
  • Adverse Reactions from Clinical Studies or Postmarketing Reportsn
  • Adverse reactions associated with insulin initiation and glucose control intensificationn
  • Hypersensitivity reactionsn
  • Hypoglycemian
  • Hypokalemian
  • Peripheral edeman
  • Weight gainn
  • Immunogenicityn
  • Adverse reactions observed with insulin human injection include hypoglycemia, allergic reactions, weight gain and edema ().
  • www.fda.gov/medwatch.
  • No data
  • Drugs that may increase the risk of hypoglycemia:
  • Drugs that may decrease the blood glucose lowering effect:
  • Drugs that may increase or decrease the blood glucose lowering effect:
  • Drugs that may blunt the signs and symptoms of hypoglycemia:
  • No data
  • Excess insulin administration may cause hypoglycemia and hypokalemia. More severe episodes with coma, seizure, or neurologic impairment can be treated with intramuscular or subcutaneous glucagon or intravenous glucose. Sustained monitoring may be necessary because hypoglycemia may recur after apparent clinical recovery. Hypokalemia must be corrected appropriately. [see n ]
  • Insulin human is a short-acting human insulin. It is a polypeptide hormone and is produced by recombinant DNA technology, utilizing (a yeast) as the production organism. Insulin human is regular human insulin and has the empirical formula CHNOS and a molecular weight of 5808.
  • Figure 1: Structural formula of Insulin Human
  • MYXREDLIN (insulin human in sodium chloride injection) for intravenous use is a sterile, preservative-free, nonpyrogenic, clear, aqueous, and colorless solution supplied in a 100 mL GALAXY single-dose container. MYXREDLIN contains 100 units of insulin human in 100 milliliters of 0.9% sodium chloride injection. Each milliliter of solution contains 1 unit Insulin Human, USP; 0.412 mg Dibasic Sodium Phosphate Anhydrous, USP; 0.29 mg Monobasic Sodium Phosphate Monohydrate, USP; 9 mg Sodium Chloride, USP; and Water for Injection, USP. The pH range is 6.5-7.2.
  • No data
  • Standard 2-year carcinogenicity studies in animals have not been performed to evaluate the carcinogenic potential of insulin human injection.
  • Human insulin is not mutagenic in the following tests: The chromosomal aberration assay in human lymphocytes, the micronucleus assay in mouse polychromatic erythrocytes, and the mutation frequency assay in Chinese hamster cells.
  • Standard reproduction and teratology studies in animals, including fertility assessments have not been conducted with insulin human injection.
  • No data
  • Arrayn- Hypoglycemia
  • Inform patients that hypoglycemia is the most common adverse reaction with insulin. Inform patients that their ability to concentrate and react may be impaired as a result of hypoglycemia.
  • Arrayn- Hypersensitivity Reactions
  • Advise patients that hypersensitivity reactions have occurred with insulin human injection [see ].
  • Manufactured by:n Deerfield, IL 60015 USA
  • Baxter, Galaxy and Myxredlin are trademarks of Baxter International Inc.
  • 07-19-01-067
  • NDC 0338-0126-12
  • MYXREDLINInsulin Humanin 0.9% Sodium Chloride Injection
  • 100 units per 100 mL(1 unit / mL)
  • 100 mL Single-Dose GALAXY container
  • Discard unused portionFor Intravenous Infusion Only
  • Insulin Human (Regular)Sterile Nonpyrogenic
  • Cautions: Do not add supplemental medication or additives.
  • Must not be used in series connections. Check for minute leaks
  • and solution clarity.
  • Each mL contains: 1 unit Insulin Human, USP; 0.412 mg Dibasic Sodium
  • Phosphate Anhydrous, USP; 0.29 mg Monobasic Sodium Phosphate
  • Monohydrate, USP; 9 mg Sodium Chloride, USP; and Water for Injection,
  • USP.
  • Dosage: See prescribing information.
  • Rx only
  • Store refrigerated at 36u00b0F to 46u00b0F (2u00b0C to 8u00b0C) in the original carton to
  • protect from light until administration. Do Not Shake. Do Not Freeze.
  • If needed, may store at room temperature up to 77u00b0F (25u00b0C) up
  • to 30 days in the original carton. Discard after 30 days if stored at
  • room temperature.
  • Baxter logo
  • Baxter, Galaxy and Myxredlin are trademarks of Baxter International Inc.
  • Baxter Healthcare Corporation
  • Deerfield, IL 60015 USA
  • Made in USA
  • Code 2G3322PL 2501 Plastic
  • 07-34-00-0384
  • For Intravenous Infusion Only
  • MYXREDLIN
  • Insulin Human
  • in 0.9% Sodium Chloride Injection
  • 100 units per 100 mL
  • (1 unit/mL)
  • NDC 0338-0126-12
  • MYXREDLINInsulin Humanin 0.9% Sodium Chloride Injection(1 unit/mL)
  • UNVARNISHED AREA FOR ON-LINEPRINTING OF LOT AND EXP
  • UPC-ABar CodePlacement
  • Sterile Nonpyrogenic
  • Each mL contains: 1 unit Insulin Human, USP; 0.412 mg Dibasic Sodium Phosphate Anhydrous,
  • USP; 0.29 mg Monobasic Sodium Phosphate Monohydrate, USP; 9 mg Sodium Chloride, USP;
  • and Water for Injection, USP.
  • Dosage:
  • Caution:
  • Rx only
  • Store refrigerated at 36u00b0F to 46u00b0F (2u00b0C to 8u00b0C) in the original carton to protect from light
  • until administration. Do Not Shake. Do Not Freeze.
  • If needed, may store MYXREDLIN at room temperature up to 77u00b0F (25u00b0C) up to 30 days in
  • the original carton. Once stored at room temperature, do not place back in the refrigerator.
  • Discard after 30 days if stored at room temperature.
  • Discard 30 days after storing at room temperature. Discard After
  • (Month) (Day) (Year)
  • (to be completed by dispensing pharmacist)
  • Baxter, Galaxy and Myxredlin are trademarks of Baxter International Inc.
  • Baxter Healthcare Corporation
  • Deerfield, IL 60015 USA
  • Made in USA
  • 07-01-00-0167
  • NDC 0338-0126-12Code 2G3322
  • MYXREDLIN
  • Insulin Human
  • in 0.9% Sodium Chloride Injection
  • 100 units per 100 mL
  • (1 unit/mL)
  • For Intravenous Infusion OnlyInsulin Human (REGULAR)
  • USE CARTON TO PROTECT CONTENTSFROM LIGHT UNTIL ADMINISTRATION
  • Rx Only
  • 1 Single-Dose Galaxy containerDiscard unused portion
  • Arrayn- Baxter Logo
  • MYXREDLINInsulin Humanin 0.9% Sodium Chloride Injection100 units per 100 mLn
  • EXP: JUN 21LOT #: NC125840n n (01)50803380126120(17)210630(21)100000002582(10)NC125840
  • Contains: 12 x 100 mL Single-Dose GALAXY Containersn- NDC 0338-0126-12
  • If needed, may store at room temperature up to 77u00b0F (25u00b0C) up to 30 days.
  • Once stored at room temperature, do not place back in the refrigerator.
  • Discard after 30 days if stored at room temperature.
  • Bar Coden
  • Rx OnlyBaxter LogoBaxter Healthcare Corporation
  • G

Similar Products

Desogestrel And Ethinyl Estradiol (Emoquette)

Desogestrel And Ethinyl Estradiol (Emoquette)

Manufacturer: REMEDYREPACK INC.

Presentation: KIT

Strength:

Pack Size:

Diphenoxylate Hydrochloride And Atropine Sulfate (Diphenoxylate Hydrochloride And Atropine Sulfate)

Diphenoxylate Hydrochloride And Atropine Sulfate (Diphenoxylate Hydrochloride And Atropine Sulfate)

Manufacturer: REMEDYREPACK INC.

Presentation: TABLET

Strength: 2.5; .025 mg/1; mg/1

Pack Size:

Fluoxetine Hydrochloride (Fluoxetine)

Fluoxetine Hydrochloride (Fluoxetine)

Manufacturer: REMEDYREPACK INC.

Presentation: CAPSULE

Strength: 40 mg/1

Pack Size:

Metoprolol Succinate (Metoprolol Succinate)

Metoprolol Succinate (Metoprolol Succinate)

Manufacturer: REMEDYREPACK INC.

Presentation: TABLET, EXTENDED RELEASE

Strength: 25 mg/1

Pack Size:

Losartan Potassium (Losartan Potassium)

Losartan Potassium (Losartan Potassium)

Manufacturer: REMEDYREPACK INC.

Presentation: TABLET, FILM COATED

Strength: 25 mg/1

Pack Size:

Browse Our Services And Processes

Comparator Sourcing for Clinical Trials

Comparator Sourcing for Clinical Trials

GNH India brings over 10 years of experience in Comparator

Read More

Name Patient Supply

Name Patient Supply

Today, the exact cause for many rare diseases remains unknown

Read More

Validated Cold Chain Shipment

Validated Cold Chain Shipment

With shifting of pharma industry from synthetic molecules to biologic

Read More

Clinical Trials Supply

Clinical Trials Supply

STOP SOURCING..... START SMART SOURCING...... COME STRAIGHT TO THE SOURCE

Read More

Pharmaceutical Contract Manufacturing

Pharmaceutical Contract Manufacturing

GNH Provides Contract Manufacturing services for: Generic Medicines with following

Read More

Pricing

Pricing

PRICING POLICY Terms of sales are typically prepaid, unless otherwise

Read More

Disclaimer

Please see the Legal Notice for detailed terms and disclaimers. The Legal Notice governs the use of this Website and by accessing and using this Website you agree to be bound by and accept the Legal Notice.

Browse from other international pharmaceuticals

General

64020 Products

GNH India Brings to over 64036 Product SKUs from India all at 1 place with easy access and global deliveries.

US NDC

71245 Products

GNH India Brings to over 71252 Product SKUs from India all at 1 place with easy access and global deliveries.

Canadian DIN

51046 Products

GNH India Brings to over 51047 Product SKUs from India all at 1 place with easy access and global deliveries.

Swiss Drugs

150 Products

GNH India Brings to over 150 Product SKUs from India all at 1 place with easy access and global deliveries.

NZ Drugs

13296 Products

GNH Brings to over 13298 Product SKUs from India all at 1 place with easy access and global deliveries.

FAQ

Check out our delivery process

Can’t find what
you’re looking for?

Contact US
Get Price

Are you an existing customer or a vendor of GNH India? Log in here to

View your Transaction
COMPANY
SERVICES
QUICK LINKS
CONTACT US
Registered Office Address:

Unit # G- 14, 15, 16, 17, Ground Floor, Prabhadevi Industrial Estate, Enterprises Industrial Premises, 408, Veer Sawarkar Road, Prabhadevi,
Mumbai 400025 India

US Office Address:

GNH Pharmaceuticals USA LLC,
Suite E # 499, 1235 EAST BLVD,
Charlotte, NC, 28203, U.S.A
TEL: +1 704 557 0412

Pharmexcil
DB
FIEO-2016
SiteLock

Copyright © 2024 GNHIndia .com. All Rights Reserved. Please read Legal Notice for further details.

Disclaimer: Product names, logos, brands and other trademarks featured or referred to are the property of their respective trademark holders.